Cellular Localization of Orexin 1 Receptor in Human Hypothalamus and Morphological Analysis of Neurons Expressing the Receptor.
Golgi staining
functional neuroanatomy
hypothalamus
orexin
orexin receptor 1
Journal
Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414
Informations de publication
Date de publication:
25 03 2023
25 03 2023
Historique:
received:
30
12
2022
revised:
21
03
2023
accepted:
23
03
2023
medline:
17
5
2023
pubmed:
16
5
2023
entrez:
16
5
2023
Statut:
epublish
Résumé
The orexin system is related to food behavior, energy balance, wakefulness and the reward system. It consists of the neuropeptides orexin A and B, and their receptors, orexin 1 receptor (OX1R) and orexin 2 receptor (OX2R). OX1R has selective affinity for orexin A, and is implicated in multiple functions, such as reward, emotions, and autonomic regulation. This study provides information about the OX1R distribution in human hypothalamus. The human hypothalamus, despite its small size, demonstrates a remarkable complexity in terms of cell populations and cellular morphology. Numerous studies have focused on various neurotransmitters and neuropeptides in the hypothalamus, both in animals and humans, however, there is limited experimental data on the morphological characteristics of neurons. The immunohistochemical analysis of the human hypothalamus revealed that OX1R is mainly found in the lateral hypothalamic area, the lateral preoptic nucleus, the supraoptic nucleus, the dorsomedial nucleus, the ventromedial nucleus, and the paraventricular nucleus. The rest of the hypothalamic nuclei do not express the receptor, except for a very low number of neurons in the mammillary bodies. After identifying the nuclei and neuronal groups that were immunopositive for OX1R, a morphological and morphometric analysis of those neurons was conducted using the Golgi method. The analysis revealed that the neurons in the lateral hypothalamic area were uniform in terms of their morphological characteristics, often forming small groups of three to four neurons. A high proportion of neurons in this area (over 80%) expressed the OX1R, with particularly high expression in the lateral tuberal nucleus (over 95% of neurons). These results were analyzed, and shown to represent, at the cellular level, the distribution of OX1R, and we discuss the regulatory role of orexin A in the intra-hypothalamic areas, such as its special role in the plasticity of neurons, as well as in neuronal networks of the human hypothalamus.
Identifiants
pubmed: 37189339
pii: biom13040592
doi: 10.3390/biom13040592
pmc: PMC10135972
pii:
doi:
Substances chimiques
Orexins
0
Orexin Receptors
0
Neuropeptides
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Ann N Y Acad Sci. 2010 Jul;1200:149-61
pubmed: 20633143
Neurosci Bull. 2020 Apr;36(4):432-448
pubmed: 31782044
Front Neurol Neurosci. 2021;45:38-51
pubmed: 34052810
Regul Pept. 2005 Jan 15;124(1-3):81-7
pubmed: 15544844
J Clin Endocrinol Metab. 2001 Apr;86(4):1616-9
pubmed: 11297593
Nat Rev Neurosci. 2014 Nov;15(11):719-31
pubmed: 25301357
Curr Biol. 2014 Dec 1;24(23):R1111-6
pubmed: 25465326
J Neurosci. 2010 Sep 22;30(38):12642-52
pubmed: 20861370
Brain Res. 2018 Jul 1;1690:89-95
pubmed: 29630859
J Endocrinol. 2006 Oct;191(1):129-36
pubmed: 17065396
J Anat. 2013 Apr;222(4):473-80
pubmed: 23425077
Int J Neurosci. 2007 Jan;117(1):25-46
pubmed: 17365098
Behav Brain Res. 2023 Feb 2;437:114123
pubmed: 36154849
J Comp Neurol. 2012 Jun 15;520(9):1831-90
pubmed: 22488503
Gen Comp Endocrinol. 2011 Apr 1;171(2):124-30
pubmed: 21216246
Brain Sci. 2021 Dec 10;11(12):
pubmed: 34942932
J Neurophysiol. 2022 May 1;127(5):1221-1229
pubmed: 35353632
Neurosci Lett. 2012 Jan 6;506(1):111-5
pubmed: 22079339
Eur J Neurosci. 2010 Nov;32(9):1528-36
pubmed: 21089218
Vitam Horm. 2022;118:393-421
pubmed: 35180935
Sci Rep. 2018 Oct 23;8(1):15666
pubmed: 30353025
Cancer Res. 2011 May 1;71(9):3341-51
pubmed: 21415167
Eur J Neurosci. 2002 Jan;15(2):315-28
pubmed: 11849298
Nat Neurosci. 2014 Oct;17(10):1298-303
pubmed: 25254979
Sci Rep. 2022 Apr 28;12(1):6571
pubmed: 35484180
Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):322-7
pubmed: 9419374
Brain Res. 1999 Sep 18;842(1):256-61
pubmed: 10526122
Behav Brain Res. 2023 Feb 13;438:114171
pubmed: 36280008
Front Neurosci. 2013 Dec 30;7:257
pubmed: 24415993
Ultrastruct Pathol. 2007 Nov-Dec;31(6):401-7
pubmed: 18098058
J Clin Endocrinol Metab. 2004 Apr;89(4):1957-62
pubmed: 15070969
Handb Clin Neurol. 2021;180:187-200
pubmed: 34225929
Biol Psychiatry. 2022 Dec 1;92(11):836-844
pubmed: 36328706
Endocrinology. 2001 Aug;142(8):3324-31
pubmed: 11459774
Nat Rev Neurosci. 2007 Mar;8(3):171-81
pubmed: 17299454
J Comp Neurol. 2001 Jun 18;435(1):6-25
pubmed: 11370008
Front Neurosci. 2020 Jul 10;14:691
pubmed: 32754010
J Neurol Neurosurg Psychiatry. 1998 Oct;65(4):446-53
pubmed: 9771764
Front Endocrinol (Lausanne). 2013 Mar 06;4:18
pubmed: 23508038
Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):12150-5
pubmed: 16880388
Cell. 1998 Feb 20;92(4):573-85
pubmed: 9491897
Gen Comp Endocrinol. 2017 Jan 1;240:103-113
pubmed: 27664717
Peptides. 2006 Apr;27(4):871-7
pubmed: 16202475
Brain Res. 2010 Feb 16;1314:74-90
pubmed: 19815001
Nat Commun. 2020 Dec 10;11(1):6326
pubmed: 33303759
Front Neurol Neurosci. 2021;45:22-37
pubmed: 34052813
Front Physiol. 2017 May 31;8:357
pubmed: 28620314
Front Pharmacol. 2020 Jan 23;10:1547
pubmed: 32038236
Brain Res. 2014 Sep 4;1579:20-34
pubmed: 25017945
Front Neuroanat. 2016 Nov 01;10:107
pubmed: 27847469
J Neurosci. 1998 Dec 1;18(23):9996-10015
pubmed: 9822755
Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):8018-8027
pubmed: 30923123
J Comp Neurol. 2000 Jul 24;423(2):299-318
pubmed: 10867660
Endocrinology. 2008 Jul;149(7):3355-60
pubmed: 18403488
J Neuroendocrinol. 2004 Apr;16(4):403-8
pubmed: 15089982
Horm Behav. 2000 Jun;37(4):335-44
pubmed: 10860677
J Clin Endocrinol Metab. 2001 Oct;86(10):4808-13
pubmed: 11600545
Peptides. 2002 Jun;23(6):1177-80
pubmed: 12126748
Endocrinology. 2003 Apr;144(4):1219-25
pubmed: 12639903
Cereb Circ Cogn Behav. 2021 Dec 31;3:100035
pubmed: 36324409
FEBS Lett. 1998 Oct 30;438(1-2):71-5
pubmed: 9821961
Neuroscience. 1989;32(2):435-9
pubmed: 2586758
Curr Alzheimer Res. 2013 Jun;10(5):469-75
pubmed: 23627706